Open Label Study of Omacetaxine Mepesuccinate in Patients With Advanced CML
Study Title
- Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML
Teva Identifier
- CGX-635-CML-203 | 2007-001286-15
ClinicalTrials.gov Identifier
- NCT00462943
Study Status
- Completed
Trial Condition(s)
- Chronic Myeloid Leukemia
Interventions
- Drug: Omacetaxine mepesuccinate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 03/01/2007 - 09/01/2013
Phase
- Phase 2
Study Type
Interventional
